Willfar(688100)2025-04-25 10:10Financial Performance - The company's operating revenue for Q1 2025 was CNY 555,425,609.19, representing a year-on-year increase of 23.96% compared to CNY 448,074,674.15 in the same period last year[4]. - The net profit attributable to shareholders for the same period was CNY 139,366,328.87, reflecting a growth of 25.33% from CNY 111,200,021.77 year-on-year[4]. - The net profit after deducting non-recurring gains and losses was CNY 136,724,141.86, which is a 26.22% increase from CNY 108,320,794.49 in the previous year[4]. - The diluted earnings per share for Q1 2025 were CNY 0.28, an increase of 21.74% compared to CNY 0.23 in the same period last year[4]. - The total profit for Q1 2025 was ¥161,065,364.97, an increase from ¥130,266,002.72 in Q1 2024[20]. Cash Flow - The net cash flow from operating activities increased by 38.29%, amounting to CNY 79,859,686.29, primarily due to an increase in sales receipts[5][7]. - Cash flow from operating activities for Q1 2025 was ¥79,859,686.29, an increase from ¥57,748,159.47 in Q1 2024[22]. - Cash flow from investing activities showed a net outflow of ¥676,492,108.37 in Q1 2025, compared to a net outflow of ¥491,416,596.23 in Q1 2024[23]. - The company reported cash and cash equivalents of ¥1,031,753,482.78 at the end of Q1 2025, down from ¥1,122,880,604.90 at the end of Q1 2024[23]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,046,193,073.39, up 1.80% from CNY 4,957,092,465.71 at the end of the previous year[5]. - The total assets as of March 31, 2025, were RMB 5.046 billion, compared to RMB 4.957 billion at the end of 2024[17]. - The total liabilities increased to RMB 1.883 billion from RMB 1.606 billion at the end of 2024[17]. Research and Development - The company's R&D expenditure totaled CNY 49,365,380.46, which accounted for 8.89% of operating revenue, down from 10.54% in the previous year[5]. - As of the end of the reporting period, the company employed 439 R&D personnel, accounting for 51.8% of the total workforce[11]. - The company added 23 new patents during the reporting period, including 5 invention patents, bringing the total to 743 effective patents[11]. - Research and development expenses for Q1 2025 were ¥49,365,380.46, slightly up from ¥47,246,952.87 in Q1 2024[19]. Revenue Breakdown - Domestic revenue reached RMB 455.09 million, up 22.57% year-on-year, while overseas revenue was RMB 96.92 million, growing by 30.58%[11]. - New contracts signed from the beginning of the year to the end of the reporting period totaled RMB 777 million, a year-on-year increase of 30.41%[11]. - The company had a backlog of contracts amounting to RMB 4.108 billion, reflecting a year-on-year growth of 17.86%[11]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,351[8]. - The company repurchased a total of 2.1465 million shares, representing 0.4366% of the total share capital, with a total expenditure of RMB 78.80 million[13].